工程化纳米细胞通过废除前列腺素介导的免疫抑制来抑制瘤的进展
Poonam Yadav1, Kajal Rana1, Viviani Nardini2
1Laboratory of Nanotechnology and Chemical Biology, Regional Centre for Biotechnology, 3(rd) Milestone Faridabad-Gurgaon Expressway, NCR Biotech Cluster, Faridabad 121001, Haryana, India.
概括
装有多塞塔克塞尔和甲的工程纳米细胞有效地对抗免疫抑制瘤微环境. 这种新型的癌症疗法增强了抗瘤免疫力,通过向炎症和细胞增殖,提高了生存率.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 免疫学 免疫学 免疫学
背景情况:
- 瘤微环境 (TME) 通常会抑制抗癌免疫力.
- 在TME内的炎症和免疫抑制细胞阻碍了有效的癌症治疗.
研究的目的:
- 设计一种结合多塞 (DTX) 和甲 (DEX) 的新型仿真纳米细胞 (NMs).
- 评估DTX-DEX NMs在改变免疫抑制TME和增强抗癌活性方面的疗效.
主要方法:
- 脂-DTX和PEGylated-lipid-DEX结合物的自我组装成为100nm以下的化学NMS.
- 在同源和异源移植小鼠模型中评估抗癌活性.
- 在TME内分析免疫细胞群,细胞因子表达和前列腺素合成.
主要成果:
- 与其他治疗方法相比,DTX-DEX NMs显示出优异的瘤回归和增强小鼠存活率.
- NMs显著降低了髓质衍生的抑制细胞和调节的巨细胞极化.
- 细胞毒性CD4+和CD8+T细胞的积累增强,以及改变的细胞因子配置.
- 通过向环氧基因酶2观察到抑制前列腺素合成,特别是PGE2.
结论:
- 石英酸衍生的化学NMS有效地重新编程免疫抑制的TME.
- DTX-DEX NMs通过调节前列腺素通路并增强抗瘤免疫力,为癌症治疗提供了一个有希望的策略.
- 这种方法导致瘤进展的缓解和改善生存结果.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.0K
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
